If you’ve been exposed to Roundup and developed cancer, 2026 could be your window to seek compensation through one of the largest mass tort cases in American history. Roundup lawsuit mass tort case leads are driving thousands of new claims as Bayer continues to face billions in potential liability.
This guide breaks down everything you need to know about qualifying for the Roundup lawsuit, expected settlement amounts, filing deadlines, and the 2026 outlook. It also covers related mass torts like paraquat, PFAS, and AFFF.
Over 100,000 Roundup lawsuits have been filed against Bayer since it acquired Monsanto. That number keeps growing. If you or someone you know has been affected, this is what you need to understand right now.
Roundup Lawsuit Mass Tort Case Leads
Roundup lawsuit mass tort case leads are individuals who have used Roundup weed killer and later developed non-Hodgkin lymphoma or other cancers linked to glyphosate exposure. These people represent potential claimants in the ongoing litigation against Bayer AG.
When you hear the term “case lead,” it simply means someone who has been identified as a possible plaintiff. You might fill out a form online, speak with a legal team, or get screened through a qualifying process. Once your exposure history and diagnosis are confirmed, you become an active case.
The Roundup mass tort is one of the largest product liability cases in U.S. history. Bayer has already set aside more than $16 billion in settlement reserves since acquiring Monsanto in 2018.
| Key Fact | Detail |
|---|---|
| Herbicide at Issue | Roundup (glyphosate) |
| Defendant | Bayer AG (formerly Monsanto) |
| Primary Health Claim | Non-Hodgkin lymphoma |
| Cases Filed | Over 100,000 |
| MDL Court | U.S. District Court, Northern District of California |
| MDL Number | 2741 |
New case leads are still being accepted in 2026. The litigation is far from over, and fresh claims keep entering the system.
Being a case lead doesn’t cost you anything upfront. Most attorneys handling these cases work on a contingency basis, meaning they only get paid if you win.
Roundup Lawsuit 2026 Update
The Roundup litigation is entering a critical phase in 2026. Bayer lost several bellwether trials in prior years, with juries awarding hundreds of millions in damages to individual plaintiffs.
In 2024 and 2025, Bayer attempted to create a class-wide settlement structure to resolve future claims. Courts pushed back on some of these proposals, which means individual and group settlements will likely continue through 2026.
Bayer’s legal strategy in 2026 focuses on limiting future liability. The company has explored reformulating Roundup for residential use by removing glyphosate, but this doesn’t affect existing claims from past exposure.
- Bayer lost the Hardeman, Pilliod, and Johnson bellwether trials
- Jury awards ranged from $80 million to $2.25 billion before reductions on appeal
- The U.S. Supreme Court declined to hear Bayer’s appeal in 2025, keeping the litigation alive
- New claims are still being filed in both state and federal courts
The 2026 outlook suggests that Bayer will continue negotiating settlements rather than risk more massive jury verdicts. Claimants who file early in 2026 may benefit from ongoing settlement momentum.
Judge Vince Chhabria continues to oversee the MDL 2741 proceedings in San Francisco. His rulings in 2026 will shape how remaining cases move forward.
Who Qualifies for Roundup Lawsuit
You qualify for the Roundup lawsuit if you were exposed to Roundup or other glyphosate-based herbicides and later developed a qualifying medical condition, primarily non-Hodgkin lymphoma.
Qualification isn’t limited to farmers or agricultural workers. Homeowners, landscapers, groundskeepers, and anyone who regularly used Roundup products may be eligible.
The key factors that determine eligibility include how long you used the product, how often you were exposed, and when your diagnosis occurred.
| Qualification Factor | What Courts Look For |
|---|---|
| Product Used | Roundup or any glyphosate herbicide |
| Duration of Use | Regular use over months or years |
| Diagnosis | Non-Hodgkin lymphoma (various subtypes) |
| Timing | Diagnosis after period of exposure |
| Proof Required | Medical records, purchase history, testimony |
You don’t need to have exact receipts from every Roundup purchase. Witness statements, photos, and employment records can support your claim.
People who used Roundup professionally tend to have stronger claims. But residential users who sprayed it on their lawns for years have also won significant verdicts.
If a family member used Roundup regularly and has since passed away from NHL, surviving relatives may be able to file a wrongful death claim.
Key Takeaway: Anyone who used Roundup regularly and developed non-Hodgkin lymphoma should explore their eligibility for the 2026 mass tort, regardless of whether they were professional or residential users.
Roundup Cancer Lawsuit Eligibility
Roundup cancer lawsuit eligibility centers on a diagnosed link between glyphosate exposure and specific cancer types. Non-Hodgkin lymphoma is the primary qualifying diagnosis, but several subtypes and related conditions are included.
The International Agency for Research on Cancer (IARC), part of the World Health Organization, classified glyphosate as “probably carcinogenic to humans” in 2015. That classification has been a cornerstone of the litigation.
Eligible cancer diagnoses include:
- Diffuse large B-cell lymphoma (DLBCL)
- Follicular lymphoma
- Chronic lymphocytic leukemia (CLL)
- Mantle cell lymphoma
- Marginal zone lymphoma
- Hairy cell leukemia
- Other B-cell and T-cell non-Hodgkin lymphoma subtypes
You don’t need to prove that Roundup was the sole cause of your cancer. You need to show that your exposure was a “substantial contributing factor” to your diagnosis.
Medical experts will review your records as part of the case evaluation process. A qualified oncologist’s opinion linking your exposure history to your diagnosis strengthens your claim significantly.
People diagnosed before they ever used Roundup would not qualify. The diagnosis must come after a period of documented or testified exposure to glyphosate products.
Roundup Settlement 2026
Roundup settlement amounts in 2026 are expected to vary widely based on individual case strength, severity of illness, and duration of exposure. There is no single fixed payout for every claimant.
Bayer has already paid out billions in settlements. The company’s $10.9 billion settlement agreement in 2020 resolved roughly 80% of the cases pending at that time. But tens of thousands of new claims have been filed since then.
| Settlement Tier | Estimated Range | Case Characteristics |
|---|---|---|
| Tier 1 (Severe) | $150,000 to $250,000+ | Aggressive NHL, long exposure, strong evidence |
| Tier 2 (Moderate) | $50,000 to $150,000 | Confirmed NHL, moderate exposure history |
| Tier 3 (Lower) | $5,000 to $50,000 | Shorter exposure, weaker documentation |
| Trial Verdicts | $20 million to $2 billion+ | Cases that go to trial (rare but impactful) |
Settlement payouts that come through negotiated agreements are typically much lower than jury verdicts. But they’re also more certain and arrive faster.
In 2026, Bayer may offer new settlement rounds to clear the backlog of claims. Claimants with strong medical documentation and clear exposure timelines will likely receive offers at the higher end.
Most individual settlements take 6 to 18 months to finalize after an agreement is reached. That’s because medical records need review and attorneys negotiate final numbers.
Mass Tort Settlement Amounts 2026
Mass tort settlement amounts in 2026 depend on the specific litigation, the defendant’s financial capacity, and the number of claimants in the pool. Roundup, paraquat, PFAS, and AFFF all have different payout structures.
Think of it like insurance claims after a natural disaster. Everyone files, but the amount you receive depends on the damage you personally suffered and how well you documented it.
| Mass Tort | Expected 2026 Settlement Range | Status |
|---|---|---|
| Roundup (Glyphosate) | $5,000 to $250,000+ | Active settlements and trials |
| Paraquat | $100,000 to $500,000+ (projected) | Early stages, no global settlement yet |
| PFAS (Water) | $10,000 to $300,000+ (projected) | Municipal and individual claims proceeding |
| AFFF (Foam) | $40,000 to $300,000+ (projected) | MDL active, bellwether trials underway |
These ranges are estimates based on prior mass tort patterns and early case results. Actual amounts will shift as litigation progresses through 2026.
Several factors affect your individual payout:
- Severity of your medical condition
- Length and intensity of your chemical exposure
- Quality of your documentation (medical records, work history, purchase records)
- Whether your case goes to trial or settles
Mass tort settlements are not like class action settlements where everyone gets the same small check. Each claim is evaluated individually, which is why payouts can differ by hundreds of thousands of dollars.
Key Takeaway: Settlement amounts across all four major mass torts in 2026 will vary significantly based on individual circumstances, with the strongest cases potentially worth six figures or more.
How to File a Roundup Lawsuit
Filing a Roundup lawsuit in 2026 starts with contacting a law firm that handles mass tort cases and completing an intake evaluation. The process is straightforward, and you won’t pay anything out of pocket to begin.
Here’s the step-by-step process:
- Contact a mass tort attorney who handles Roundup claims
- Complete an intake questionnaire about your Roundup use and health history
- Provide medical records documenting your cancer diagnosis
- Sign a retainer agreement with the law firm (contingency fee, no upfront cost)
- Your attorney files the complaint in the appropriate court
- Case proceeds through MDL or state court litigation
You’ll need to gather some basic information before you start. Having your diagnosis date, treatment records, and an estimate of how long you used Roundup will speed things up.
| What You Need | Why It Matters |
|---|---|
| Medical records showing NHL diagnosis | Proves qualifying condition |
| Exposure history (years of use) | Shows duration and intensity |
| Product identification (Roundup brand) | Connects you to the defendant |
| Employment records (if occupational) | Strengthens exposure claims |
| Witness statements | Corroborates your use |
Most firms complete the intake process within 1 to 2 weeks. After filing, your case joins the MDL 2741 proceedings or a state court docket.
The entire process from filing to settlement can take 12 to 36 months, depending on where your case lands in the queue and whether Bayer offers a settlement or your case goes toward trial.
Roundup Lawsuit Deadline 2026
The deadline to file a Roundup lawsuit depends on the statute of limitations in your state, which typically runs 2 to 4 years from the date you were diagnosed with cancer or discovered the link between your illness and Roundup.
There is no single national deadline that applies to everyone. Each state sets its own rules.
| State | Statute of Limitations | Notes |
|---|---|---|
| California | 2 years from discovery | Discovery rule applies |
| Texas | 2 years from injury | Strict deadline |
| Florida | 4 years from discovery | Longer window |
| New York | 3 years from discovery | Standard personal injury |
| Illinois | 2 years from discovery | Discovery rule applies |
The “discovery rule” is key here. Your clock doesn’t necessarily start when you were exposed to Roundup. It starts when you knew, or reasonably should have known, that Roundup caused your condition.
If you were diagnosed with NHL in 2024 and learned about the Roundup connection in 2025, your filing clock may have started in 2025. That means 2026 could be your last year to file in states with a 2-year limit.
Waiting too long is the biggest mistake people make. Once your statute of limitations expires, your claim is gone forever. No exceptions, no extensions in most cases.
If you’re unsure about your state’s deadline, get a case evaluation as soon as possible. The screening process itself doesn’t commit you to anything.
Roundup Non-Hodgkin Lymphoma Lawsuit
The Roundup non-Hodgkin lymphoma lawsuit is the core of the entire Roundup litigation. NHL is the primary cancer type linked to glyphosate exposure in scientific studies and court proceedings.
Non-Hodgkin lymphoma is a group of blood cancers that develop in the lymphatic system. It’s not one disease but a collection of related cancers, and several subtypes have been connected to Roundup use.
The connection between Roundup and NHL gained major traction in 2015 when IARC classified glyphosate as a probable human carcinogen. Multiple epidemiological studies, including the Agricultural Health Study, have examined this link.
Key trial results in the NHL litigation:
- Johnson v. Monsanto (2018): Jury awarded $289 million (reduced to $78 million on appeal)
- Hardeman v. Monsanto (2019): Jury awarded $80 million (reduced to $25 million on appeal)
- Pilliod v. Monsanto (2019): Jury awarded $2.055 billion (reduced to $86.7 million on appeal)
These verdicts established that juries are willing to hold Bayer responsible for NHL linked to Roundup. The pattern of verdicts has driven Bayer’s willingness to settle.
In 2026, NHL remains the strongest qualifying diagnosis. If you have a different cancer type, your case may still be evaluated, but NHL provides the clearest legal pathway.
Key Takeaway: Non-Hodgkin lymphoma is the primary qualifying diagnosis in the Roundup litigation, and jury verdicts have consistently supported the link between glyphosate and this cancer.
Mass Tort Lead Generation Explained
Mass tort lead generation is the process of identifying and connecting people who have been harmed by a product or substance with attorneys who can represent them. It’s how law firms find potential clients for cases like Roundup.
When you see a TV commercial asking “Have you or a loved one been diagnosed with cancer after using Roundup?” that’s lead generation in action. The same thing happens through online ads, social media, and lawsuit information websites.
Here’s how the process works from your perspective:
- You see information about the Roundup lawsuit
- You fill out a screening form or call a phone number
- A legal intake specialist asks about your exposure and diagnosis
- If you meet the criteria, you’re connected with an attorney
- The attorney evaluates your case and decides whether to file
You are never charged for this screening. Law firms pay for the lead generation, not you.
| Lead Generation Method | How It Works |
|---|---|
| TV advertising | Commercials during daytime and prime time |
| Digital advertising | Google, Facebook, and YouTube ads |
| Lawsuit information websites | Articles and screening forms |
| Referral networks | Doctors, community groups, word of mouth |
| Direct mail | Letters sent to people in affected areas |
Being a “lead” doesn’t mean you’re committed to anything. You can go through the screening and decide not to proceed. There’s zero obligation until you sign a retainer agreement with a law firm.
The quality of lead generation matters. Reputable firms verify your diagnosis and exposure before moving forward. Be cautious of anyone who guarantees a specific payout before reviewing your case.
Paraquat Lawsuit Mass Tort Case Leads
Paraquat lawsuit mass tort case leads are individuals exposed to the herbicide paraquat dichloride who have developed Parkinson’s disease. This litigation targets manufacturers including Syngenta and Chevron.
Paraquat is one of the most toxic herbicides sold in the United States. It’s been banned in the European Union and over 30 other countries, but it remains legal for commercial agricultural use in the U.S. Only licensed applicators can purchase and apply it.
The paraquat mass tort gained significant momentum in 2021 when the Judicial Panel on Multidistrict Litigation consolidated cases into MDL 2873 in the Southern District of Illinois.
| Key Fact | Detail |
|---|---|
| Chemical | Paraquat dichloride |
| Primary Health Claim | Parkinson’s disease |
| Manufacturers | Syngenta, Chevron Phillips |
| MDL Number | 2873 |
| MDL Court | Southern District of Illinois |
| Cases Filed | Over 5,000 |
In 2026, bellwether trials are expected to begin shaping the litigation’s trajectory. No global settlement has been reached yet, which means individual case values could be substantial for early claimants.
People who qualify include:
- Farm workers who mixed or applied paraquat
- Agricultural laborers exposed through drift or residue
- Residents living near farms where paraquat was sprayed
- Licensed applicators who handled the chemical directly
If you were exposed to paraquat and later diagnosed with Parkinson’s disease, 2026 is a critical time to explore your legal options. The litigation is still in its growth phase.
Paraquat Lawsuit Eligibility 2026
Paraquat lawsuit eligibility in 2026 requires a documented history of exposure to paraquat and a diagnosis of Parkinson’s disease. Unlike Roundup, where the cancer diagnosis is the focus, the paraquat litigation centers on neurological damage.
Studies published in journals like the American Journal of Epidemiology have found that paraquat exposure increases the risk of Parkinson’s disease by approximately 150%.
To qualify, you generally need:
- Direct or indirect exposure to paraquat (spraying, mixing, or proximity to application)
- Diagnosis of Parkinson’s disease by a qualified neurologist
- Timeline consistency showing exposure preceded the diagnosis
- No alternative cause that fully explains the Parkinson’s diagnosis (though this is a factor, not a disqualifier)
| Eligibility Factor | Threshold |
|---|---|
| Exposure Type | Occupational, residential proximity, or bystander |
| Minimum Exposure | Regular or repeated contact over time |
| Qualifying Diagnosis | Parkinson’s disease |
| Documentation Needed | Medical records, employment records, geographic evidence |
Family members of deceased individuals who were exposed to paraquat and developed Parkinson’s may file wrongful death claims in 2026.
The statute of limitations for paraquat claims varies by state, just like Roundup. Most states allow 2 to 3 years from the date of diagnosis or discovery of the connection.
Key Takeaway: Paraquat lawsuit eligibility in 2026 hinges on provable exposure to the herbicide combined with a Parkinson’s disease diagnosis, and the litigation is still early enough that new claims are being actively accepted.
PFAS Lawsuit Mass Tort Case Leads
PFAS lawsuit mass tort case leads include both municipalities and individuals affected by per- and polyfluoroalkyl substances contaminating drinking water and other environmental sources. PFAS are synthetic chemicals that don’t break down naturally, earning them the nickname “forever chemicals.”
The PFAS litigation is massive in scope. Over 6,000 cases have been filed as of early 2025, targeting manufacturers like 3M, DuPont, and Chemours.
PFAS contamination affects millions of Americans. The chemicals are found in firefighting foam, non-stick cookware, food packaging, stain-resistant fabrics, and industrial processes.
| Key Fact | Detail |
|---|---|
| Chemicals | PFOA, PFOS, GenX, and other PFAS compounds |
| Primary Defendants | 3M, DuPont, Chemours, Corteva |
| Health Claims | Kidney cancer, testicular cancer, thyroid disease, ulcerative colitis |
| MDL Number | 2873 (AFFF/PFAS consolidated) |
| MDL Court | District of South Carolina |
| Judge | Richard Gergel |
In June 2023, 3M announced a $10.3 billion settlement with public water systems. That deal covers municipal claims but doesn’t address individual health claims.
Individual PFAS case leads in 2026 are people who:
- Lived near contaminated water sources
- Worked at facilities that used or manufactured PFAS
- Were exposed through military service or firefighting
- Developed cancer or other health conditions linked to PFAS
The individual health claims track is still developing. 2026 may bring the first significant individual settlements or trial verdicts.
PFAS Water Contamination Lawsuit 2026
The PFAS water contamination lawsuit in 2026 is targeting both municipal water system cleanup and individual health damage compensation. These are two separate legal tracks, and both are advancing.
On the municipal side, 3M’s $10.3 billion settlement is being distributed to water systems that need to filter out PFAS. But that money goes to cities and water utilities, not directly to individual residents.
For individuals, the path to compensation runs through personal injury claims. If contaminated water caused your cancer or other illness, you may file your own case.
Qualifying health conditions for PFAS individual claims:
- Kidney cancer
- Testicular cancer
- Thyroid disease
- Ulcerative colitis
- Liver damage
- High cholesterol (in connection with other conditions)
- Pre-eclampsia (pregnancy-related)
| 2026 PFAS Timeline | Expected Development |
|---|---|
| Q1 2026 | Municipal settlement distribution continues |
| Q2 2026 | Individual bellwether trial selections |
| Q3-Q4 2026 | Potential first individual trial verdicts |
| Ongoing | New individual claims accepted |
The EPA set enforceable limits for PFAS in drinking water in 2024, setting maximum levels of 4 parts per trillion for PFOA and PFOS. This regulatory action strengthens the legal argument that PFAS contamination is harmful.
If you’ve been drinking water contaminated with PFAS and have a qualifying diagnosis, filing in 2026 puts you in a strong position as the litigation matures.
Key Takeaway: The PFAS litigation in 2026 is split between municipal water cleanup settlements and individual health claims, with the individual track expected to produce its first major trial outcomes this year.
AFFF Lawsuit Mass Tort Case Leads
AFFF lawsuit mass tort case leads are people exposed to aqueous film-forming foam who developed cancer or other serious health conditions. AFFF contains PFAS chemicals and was widely used by military personnel, firefighters, and workers at airports and industrial sites.
The AFFF litigation is closely tied to the broader PFAS legal battle. Both involve the same “forever chemicals,” but AFFF cases focus specifically on exposure through firefighting foam.
Over 7,000 AFFF-related cases have been consolidated in the MDL before Judge Richard Gergel in the District of South Carolina.
| Key Fact | Detail |
|---|---|
| Product | Aqueous film-forming foam (AFFF) |
| PFAS Chemicals | PFOA, PFOS, and related compounds |
| Primary Defendants | 3M, DuPont, Chemours, Tyco, Kidde |
| Affected Groups | Firefighters, military, airport workers |
| Primary Claims | Cancer, thyroid disease, immune disorders |
| MDL | Consolidated in District of South Carolina |
People who qualify as AFFF case leads include:
- Municipal and military firefighters who trained with or used AFFF
- Military personnel stationed at bases where AFFF was used
- Airport crash rescue workers
- Industrial workers at facilities using foam fire suppression
- Community members near military bases or training sites
AFFF was used for decades as the standard foam for fighting fuel fires. The Department of Defense required its use at military installations, exposing hundreds of thousands of service members.
In 2026, the AFFF litigation is expected to produce its first bellwether trial results, which will set the tone for future settlements.
AFFF Firefighting Foam Lawsuit 2026
The AFFF firefighting foam lawsuit in 2026 stands at a turning point. Bellwether trials are expected to deliver the first individual health claim verdicts, giving both sides a benchmark for settlement negotiations.
Unlike the municipal PFAS water settlements, AFFF individual cases focus on direct occupational exposure. Firefighters and military personnel who handled the foam regularly tend to have the highest exposure levels and the strongest claims.
Health conditions linked to AFFF exposure in the litigation:
- Kidney cancer
- Testicular cancer
- Bladder cancer
- Prostate cancer
- Thyroid disease
- Non-Hodgkin lymphoma
- Liver cancer
| 2026 AFFF Lawsuit Milestones | Expected Timing |
|---|---|
| Bellwether trial selections finalized | Early 2026 |
| First individual trial verdicts | Mid to late 2026 |
| Settlement negotiations (if verdicts favor plaintiffs) | Late 2026 into 2027 |
| New claims still accepted | Throughout 2026 |
The Department of Defense began phasing out PFAS-containing AFFF in 2024, replacing it with fluorine-free alternatives. This shift signals an acknowledgment of the health risks, which strengthens plaintiff arguments.
If you served as a firefighter or military personnel and used AFFF regularly, 2026 is the year to get your case evaluated. Bellwether trial results will heavily influence future settlement values.
Projected individual settlement amounts for strong AFFF cases range from $40,000 to $300,000 or more, depending on cancer type, exposure duration, and case documentation.
Paraquat vs Roundup Lawsuit Differences
The paraquat and Roundup lawsuits target different chemicals, different health conditions, and different manufacturers. Understanding the differences helps you determine which case applies to you.
Both are herbicide lawsuits. Both are mass torts. But that’s where the similarities end.
| Factor | Roundup Lawsuit | Paraquat Lawsuit |
|---|---|---|
| Chemical | Glyphosate | Paraquat dichloride |
| Manufacturer | Bayer/Monsanto | Syngenta/Chevron |
| Health Claim | Non-Hodgkin lymphoma | Parkinson’s disease |
| MDL Number | 2741 | 2873 |
| Cases Filed | 100,000+ | 5,000+ |
| Settlement Status | Billions paid, ongoing | No global settlement yet |
| Who Used It | Farmers, homeowners, landscapers | Licensed commercial applicators only |
| Current Phase | Mature litigation | Earlier stage |
Roundup was sold to consumers at hardware stores and garden centers. Paraquat, on the other hand, is restricted to licensed commercial applicators. You couldn’t buy paraquat at your local Home Depot.
This distinction matters. Roundup claimants include a much wider population: homeowners, weekend gardeners, and groundskeepers. Paraquat claimants tend to be professional agricultural workers.
The health conditions are completely different too. Roundup targets blood cancers. Paraquat targets the nervous system. If you have both NHL and Parkinson’s disease and were exposed to both chemicals, you could potentially file in both mass torts.
Paraquat cases may ultimately yield higher individual payouts because fewer claims exist and the toxicity of the chemical is extreme. But this remains speculative until trial results come in.
Key Takeaway: Roundup and paraquat lawsuits are separate mass torts with different qualifying health conditions, different defendants, and different stages of litigation, so make sure you identify the right case for your situation.
Mass Tort Case Leads for Attorneys
Mass tort case leads for attorneys are pre-screened potential clients who meet the basic qualification criteria for a specific litigation. For law firms handling Roundup, paraquat, PFAS, or AFFF cases, quality leads are the lifeblood of their practice.
If you’re an attorney reading this, here’s what the 2026 market looks like for mass tort lead acquisition across the four biggest chemical exposure litigations.
| Mass Tort | Lead Availability | Cost Per Lead (Estimated) | Lead Quality Trend |
|---|---|---|---|
| Roundup | High volume | $150 to $500 per signed case | Declining (market saturation) |
| Paraquat | Moderate volume | $200 to $600 per signed case | Rising (growing awareness) |
| PFAS | Growing rapidly | $100 to $400 per signed case | High (new EPA regulations driving interest) |
| AFFF | Moderate volume | $200 to $500 per signed case | High (military/firefighter targeting) |
Lead quality matters more than volume. A single well-documented Roundup case with strong medical evidence is worth more than ten cases with thin exposure histories.
For attorneys entering these mass torts in 2026, the key metrics to evaluate lead providers on include:
- Qualification rate: What percentage of leads become signed cases?
- Retention rate: How many signed clients stay with the case long-term?
- Documentation quality: Do leads come with preliminary medical and exposure records?
- Exclusivity: Are leads sold to one firm or shared among multiple?
The mass tort lead generation industry has matured significantly. Firms that invest in verified, well-documented leads will outperform those chasing cheap volume. In 2026, quality will beat quantity across every one of these litigations.
Frequently Asked Questions
How do I know if I qualify for the Roundup lawsuit in 2026?
You qualify if you used Roundup or another glyphosate herbicide and were later diagnosed with non-Hodgkin lymphoma.
Regular use over months or years strengthens your case.
Contact a mass tort attorney for a free case evaluation to confirm your eligibility.
What is a mass tort case lead and what does it mean for me?
A mass tort case lead is a person identified as a potential claimant in a mass tort lawsuit.
It means you’ve been screened and may qualify to file a legal claim for compensation.
Being a lead doesn’t obligate you to do anything until you sign a retainer agreement.
How much money can I expect from a Roundup settlement in 2026?
Most Roundup settlements range from $5,000 to $250,000 depending on case strength.
Severe NHL cases with long exposure histories receive the highest payouts.
Trial verdicts have reached into the millions, but most cases settle for lower amounts.
Is there a deadline to file a Roundup lawsuit in 2026?
Yes, the statute of limitations varies by state, typically 2 to 4 years from diagnosis or discovery.
If you were diagnosed in 2024, your deadline could arrive in 2026 in some states.
Don’t wait to get your case evaluated because missed deadlines cannot be reversed.
What is the difference between the Roundup and paraquat lawsuits?
Roundup lawsuits involve glyphosate and non-Hodgkin lymphoma, while paraquat lawsuits involve paraquat dichloride and Parkinson’s disease.
They target different companies: Bayer for Roundup and Syngenta for paraquat.
You could potentially file in both if you were exposed to both chemicals and have both conditions.
The Roundup mass tort and related chemical exposure lawsuits are actively accepting new case leads in 2026. Whether your exposure involves glyphosate, paraquat, PFAS, or AFFF, the window to file remains open.
Check your eligibility now. Gather your medical records and exposure history. Get a free case evaluation from a qualified mass tort attorney before your state’s filing deadline passes.
Your claim has value. Don’t let the clock run out.
